A plain-English glossary of APOE4 terms

Reading about APOE4 means wading through vocabulary borrowed from genetics, neurology, and cardiology all at once. This page is the cheat sheet. Keep it open while you read. The definitions are deliberately plain, with links to the deeper dives where they exist, and many end with why the term matters for you as a carrier.

The genetics words

APOE is the gene, and the protein it makes, apolipoprotein E. Its day job is moving cholesterol and fats around the body and brain. The version you inherit is the whole reason this site exists.

Allele is one version of a gene. APOE comes in three common alleles: ε2, ε3, and ε4 (often written 2, 3, 4).

ε2 / ε3 / ε4 are those three versions. ε2 is rare and relatively protective, ε3 is the common neutral reference, and ε4 raises risk.

Genotype is your specific pair of alleles, one inherited from each parent, such as 3/4 or 4/4. This pair is what determines your risk, so it is the number to actually know. See the genotypes explained.

Carrier is shorthand for someone with at least one ε4 allele.

Homozygous / heterozygous describe the pair. Two copies of the same allele (for example ε4/ε4) is homozygous. Two different ones (for example ε3/ε4) is heterozygous. Why it matters: an ε4/ε4 homozygote carries higher risk than an ε3/ε4 heterozygote, so this distinction changes how your numbers read.

SNP (single-nucleotide polymorphism) is a single-letter spot in your DNA that varies from person to person. Your APOE type is set by just two of them, rs429358 and rs7412. Why it matters: if you are reading a raw DNA file yourself, these are the exact two rows you need. See how to read them in your raw data.

Penetrance is the fraction of people carrying a variant who actually develop the condition tied to it. APOE4 has low-to-moderate penetrance: only a subset of carriers ever develop Alzheimer’s, which is why it is called a risk factor and not a deterministic mutation. Two copies push penetrance higher (the Fortea 2024 study found ε4/ε4 behaves almost like a distinct genetic form of the disease). Why it matters: this single word is the difference between “raised odds” and “destiny,” and APOE4 is firmly the former.

Sporadic vs. familial Alzheimer’s are two different diseases that share a name. The sporadic (late-onset) form, the one APOE4 influences, makes up the vast majority of cases and has no single causative gene. Familial (autosomal-dominant, early-onset) Alzheimer’s is rare (under about 1 to 5% of cases), is caused by mutations in APP, PSEN1, or PSEN2, and is highly penetrant. Why it matters: APOE4 is a different biological story from the familial mutations, so do not read those scarier inevitability statistics as if they were about you.

The risk words

Relative risk is how much a factor changes your odds compared with a reference group. It sounds dramatic (“twice the risk”) and on its own tells you nothing about your actual chance.

Absolute risk is your actual probability over a stated time horizon, such as “by age 85.” This is the number that matters. Why it matters: headlines quote relative risk because it sounds bigger; always ask for the absolute number before you panic. See what the numbers mean.

Modifiable risk factor is an influence on risk you can actually change, such as blood pressure, activity, or sleep, as opposed to fixed ones like your genotype. Why it matters: these are where all your leverage lives.

The brain words

Amyloid-beta (Aβ) is a protein fragment that clumps into plaques between neurons, one of the two hallmarks of Alzheimer’s. Why it matters: APOE4 is linked to clearing amyloid less efficiently, which is one of the main reasons the gene raises risk.

Tau is a protein that, in disease, twists into tangles (neurofibrillary tangles, sometimes shortened to NFTs) inside neurons, the second classic Alzheimer’s hallmark. Tau tracks more closely with actual symptoms than amyloid does. That is why p-tau217, a blood marker of tau pathology, has become such a useful early signal: it tells Alzheimer’s apart from other causes with roughly 90%-plus accuracy in recent studies. See blood-based biomarkers.

Neuroinflammation is the brain’s own immune response. Helpful in short bursts, but when it becomes chronic it may speed up damage.

Blood-brain barrier is the selective border that protects brain tissue from whatever is circulating in the bloodstream. Why it matters: APOE4 is linked to its breakdown, one more channel through which the gene acts. See how APOE4 affects the brain.

Glymphatic system is the brain’s waste-clearance plumbing, most active during deep sleep. Why it matters: it is a big part of why sleep matters so much for carriers.

Cognitive reserve is the brain’s resilience, built up over a lifetime from education and mental and social engagement, that can buffer against pathology. Why it matters: it is one of the things you can keep building at any age. See social connection and cognitive reserve.

BDNF (brain-derived neurotrophic factor) is a protein that supports the growth and upkeep of neurons. Why it matters: exercise boosts it, which is part of how movement protects the brain.

MCI (mild cognitive impairment) is measurable decline beyond normal aging that does not yet derail daily life. Why it matters: it is often the earliest stage where intervention is possible. See MCI and early detection.

Biomarker is any measurable biological signal, whether in spinal fluid, on a PET scan, or increasingly in blood, that reflects what a disease process is doing.

The heart and metabolic words

LDL-C is the cholesterol carried inside LDL particles, the “bad cholesterol” line on a standard panel.

ApoB is a protein riding on every artery-clogging particle, exactly one per particle. So measuring ApoB counts those particles directly, no matter how much cholesterol each one happens to carry. Why it matters: that makes it a sharper risk signal than LDL-C, and many carriers should track it. See ApoB vs. LDL-C.

Lp(a) (“L-P-little-a”) is an LDL-like particle with an extra protein stuck to it that makes it both pro-inflammatory and prone to clotting. Levels are roughly 90% set by your genes and add cardiovascular risk on top of LDL. Why it matters: it is worth checking at least once in your life (above about 50 mg/dL, or 125 nmol/L, counts as elevated), because you cannot guess it from a normal cholesterol panel. See lipoprotein(a) and APOE4.

Insulin resistance is when your cells stop responding well to insulin, the engine behind prediabetes. Why it matters: it is a real factor in both metabolic and brain health.

VO2max is the maximum rate at which your body can use oxygen during hard exercise, and one of the single strongest predictors of long-term mortality (low fitness carries risk on par with major disease). Why it matters: it is highly trainable, which makes it one of your most powerful levers. See Zone 2 and VO2max.

The treatment and testing words

Anti-amyloid antibodies are drugs (such as lecanemab and donanemab) that clear amyloid from the brain and modestly slow early Alzheimer’s. See the deep dive.

ARIA (amyloid-related imaging abnormalities) is brain swelling (ARIA-E) or small bleeds (ARIA-H) that show up on MRI during anti-amyloid treatment. It is usually symptom-free but occasionally serious, and the risk depends heavily on genotype: in the lecanemab trial, ARIA-E occurred in roughly 5% of non-carriers, about 11% of ε3/ε4 heterozygotes, and around 33% of ε4/ε4 homozygotes. Why it matters: that gradient is exactly why your genotype now factors into treatment decisions. See anti-amyloid drugs and APOE4.

GINA is the U.S. Genetic Information Nondiscrimination Act. It protects your genetic information in health insurance and employment, but not in life, disability, or long-term-care insurance. Why it matters: this is the one practical thing to understand before you test. See how to get tested.

Genetic counselor is a trained professional who helps you understand genetic results and decide about testing on your own terms. Why it matters: a good one turns a scary raw result into a plan.

---

If a term you have hit is not here, it is a fair bet it links back to one of the deep dives. If you spot something we should add, that is exactly the kind of gap we want to close.